Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 August 2008

Gut. Published Online First: 8 April 2008. doi:10.1136/gut.2008.148791
Copyright © 2008 BMJ Publishing Group Ltd & British Society of Gastroenterology.

Recent Advances in Basic Science (commissioned only)

Emerging Role of Cannabinoids in Gastrointestinal and Liver Diseases: Basic and Clinical Aspects

Angelo A Izzo 1 and Michael Camilleri 2*

1 Univ. of Naples, Italy
2 Mayo Clinic, Rochester, MN, United States

* To whom correspondence should be addressed. E-mail: camilleri.michael{at}mayo.edu.

Accepted 20 March 2008


Abstract

A multitude of physiological effects and putative pathophysiological roles have been proposed for the endogenous cannabinoid system in the gastrointestinal tract, liver and pancreas. These range from effects on epithelial growth and regeneration, immune function, motor function, appetite control, fibrogenesis and secretion. Cannabinoids have the potential for therapeutic application in gut and liver diseases. Two exciting therapeutic applications in the area of reversing hepatic fibrosis as well as anti-neoplastic effects may have a significant impact in these significant diseases. This review critically appraises the experimental and clinical evidence supporting clinical application of cannabinoid receptor-based drugs on gastrointestinal, liver and pancreatic diseases. Application of modern pharmacological principles will most likely expand the selective modulation of cannabinoid system peripherally in humans. We anticipate that in addition to the approval in several countries of the CB1 antagonist, rimonabant, for the treatment of obesity and associated metabolic dysfunctions, other cannabinoid modulators are likely to have an impact on human disease in the future, including hepatic fibrosis and neoplasia.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Grider, J. R., Mahavadi, S., Li, Y., Qiao, L.-Y., Kuemmerle, J. F., Murthy, K. S., Martin, B. R. (2009). Modulation of motor and sensory pathways of the peristaltic reflex by cannabinoids. Am. J. Physiol. Gastrointest. Liver Physiol. 297: G539-G549 [Abstract] [Full Text]  
  • Duncan, M., Thomas, A. D., Cluny, N. L., Patel, A., Patel, K. D., Lutz, B., Piomelli, D., Alexander, S. P. H., Sharkey, K. A. (2008). Distribution and function of monoacylglycerol lipase in the gastrointestinal tract. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G1255-G1265 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs